| Friday, November 12, 2010 | |
| Inauguration | |
| 09:00-09:20 | Jeongbin Yim, President of A-IMBN Ken-ichi Arai, Founding President of A-IMBN |
| EMBO Plenary Lecture Chair: Filipinas Natividad | |
| 09:20-10:00 | Paola Ricciardi-Castagnoli, Singapore Immunology Network Title: The regulatory role of dendritic cells in the immune response |
| 10:00-10:10 | Commemorating late Prof. Arturo Falaschi - Sheikh Riazuddin, Executive Director of A-IMBN |
| 10:10-10:30 | Coffee Break |
| Cancer Chair: Ing-Kang Ho | |
| 10:30-10:50 | Hongbin Ji, Institute of Biochemistry and Cell Biology, SIBS, China Title: Identification of miR-143 as a glycolysis regulator in lung cancer |
| 10:50-11:10 | Ann-Lii Cheng, Department of Oncology, National Taiwan University Hospital Title: Developing molecular targeted therapy for endemic cancers in asia |
| 11:10-11:30 | Sumiko Watanabe, University of Tokyo, Japan Title: Application of a strategy identifying hematopoietic stem cells for analysis of stem/progenitor of solid tissues and cancers using retina as a model system |
| 11:30-13:00 LUNCH | |
| Infectious Diseases Chair: Jisnuson Svasti | |
| 13:00-13:20 | Bunpote Siridechadilok, BIOTEC, Thailand Title: Hunting dengue RNA replication complex |
| 13:20-13:40 | Ming-Fu Chang, Chinese Taipei Title: SARS-CoV spike protein trigger a novel ACE2 signaling critical for the viral pathogenesis |
| 13:40-14:00 | Nguyen Dang Quan, Biotechnology Center of Ho Chi Minh City, Vietnam Title: The roles of interleukin-33 in health and in allergic - inflammatory diseases |
| 14:00-14:20 | Ubolsree Leartsakulpanich, BIOTEC, Thailand Title: Enzymes in dTMP cycle as antimalarial targets |
| 14:20-14:40 | Coffee Break |
| Cancer & Personalized Medicine Chair: Yoshikazu Nakamura | |
| 14:40-15:00 | Chih-Hsin Yang, National Taiwan University, Chinese Taipei Title: Personalized therapy for nonsmall cell lung cancer patients |
| 15:00-15:20 | Gaoxiang Ge, Institute of Biochemistry and Cell Biology, SIBS, China Title: LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodeling |
| 15:20-15:40 | Masaaki Muramatsu, Medical and Dental University, Japan Title: Gene-environment interactions in metabolic syndrome and genetic tests |
| 15:40-16:00 | Sung Hee Baek, Seoul National University, Korea Title: Chromatin dynamics in cancer |
| Special Session for A-IMBN Supporting Inst. in Chinese Taipei Chair: Kenneth K. Wu | |
| 16:00-16:20 | Shu-Chun Teng, National Taiwan University, Chinese Taipei Title: Transcriptional and posttranslational activation of telomerase in telomere replication |
| 16:20-16:40 | Li Jung Juan, Academia Sinica, Chinese Taipei Title: Regulation of DNA methyltransferase 1 activity and recruitment in lung cancer |
| 16:40-17:00 | Chun-Hong Chen, NHRI, Chinese Taipei Title: A new genetic strategy for control Dengue virus transmission |
| 18:00-20:00 A-IMBN reception | |
| Saturday, November 13, 2010 | |
| EMBO Lecture Chair: Kenneth K. Wu | |
| 09:00-09:30 | Maria Leptin, Director, EMBO EMBO Global Initiative |
| Arthur Kornberg Memorial Lecture Chair: Ken-Ichi Arai | |
| 09:30-10:10 | Kong Peng Lam, Bioprocessing Technology Institute, A*STAR, Singapore Title: MicroRNAs and B cell responses |
| 10:10-10:30 | Coffee Break |
| Distinguished A-IMBN Lecture Chair: Jung-Yaw Lin | |
| 10:30-11:10 | Michael M. C. Lai, Chinese Taipei Title: Protein modifications and Influenza virus biology |
| Neurodegenerative Diseases Chair: Zuxun Gong | |
| 11:10-11:30 | Lan Bao, Institute of Biochemistry and Cell Biology, SIBS, China Title: Retrograde signaling of P2X3 receptor in primary sensory neurons |
| 11:30-11:50 | Jongkyeong Chung, Seoul National University, Korea Title: Mitochondrial dysfunction as a new target to treat Parkinson¡¯s disease |
| 11:50-12:10 | Naihe Jing, Institute of Biochemistry and Cell Biology, SIBS, China Title: RA regulates BMP signal duration by promoting the degradation of phosphorylated Smad1 |
| 12:10-13:30 LUNCH | |
| APEC Workshop on Advancing Biotechnology and Ensuring Sustainable Financing | |
| Session I: New Program for BT Development in APEC Economies Chair: Duong Hoa Xo | |
| 13:30-13:50 | Jiang Ge, Institute of Biochemistry and Cell Biology, SIBS, China Title: Biotechnology in China |
| 13:50-14:10 | Kanyawim Kiratikara, BIOTECH, Thailand Title: New Programs for Biotechnology Development in the APEC Economies: News from Thailand |
| 14:10-14:30 | Chung-Liang Chien, National Taiwan University College of Medicine, Chinese Taipei Title: National Research Program for Biopharmaceuticals (NRPB) |
| 14:30-14:50 | Thai Nyugen, Saigon Hi-Tech Park (SHTP), Vietnam Title: Vietnam biotechnology development, potentials for future progress and biotech program at Saigon Hi-Tech Park |
| 14:50-15:10 | Tai Hyun Park, Seoul National University, Korea Title: Bio-MAX Institute at Seoul National University |
| 15:10-15:30 | Jay Padasian, Health Care Industry Development Div., MBC Title: Malaysia¡¯s Biotech Value Proposition |
| 15:30-15:50 | Coffee Break |
| Session II: eIMBL: State-of-Art Virtual Laboratory Network Chair: Jeongbin Yim | |
| 15:50-16:10 | Hisao Masai, Tokyo Metropolitan Institute of Medical Science, Japan Title: Regulation of replication program and maintenance of genetic integrity in fission yeast and mammalian cells |
| 16:10-16:30 | Do Han Kim, Gwangju Institute of Science and Technology, Korea Title: Systems biology of cardiac hypertrophy (CH) through transcriptomic profiling by RNA-Seq |
| 16:30-16:50 | Ueng-Cheng Yang, National Yang-Ming University, Chinese Taipei Title: Gene-gene interaction and diseases |
| 16:50-17:10 | Matthew Salter, Nature Asia Pacific Group Title: A-IMBN Research |
| 18:00-20:00 Formosa Association Reception | |
| Sunday, November 14, 2010 | |
| Session III: eIMBL Workshop on Cell Therapy for Cancer Chair: Hong-Nerng Ho | |
| 09:00-09:10 | Ken-ichi Arai, SBI Biotech, Japan Title: Challenge and promise in immuno cell therapy |
| 09:10-09:30 | Byoung S. Kwon, National Cancer Center, Korea Title: 4-1BB (CD137)-based immunotherapy |
| 09:30-09:50 | Kazuhiro Yoshikawa, Aichi Medical University Hospital, Japan Title: Cytotoxic T-lymphocyte (CTL) therapy at Aichi Medical University |
| 09:50-10:10 | Hideaki Tahara, The University of Tokyo, Japan Title: Cancer vaccination using tumor cells in situ as the source of tumor antigens |
| 10:10-10:30 | Wen-Fang Cheng, National Taiwan University, Chinese Taipei Title: Strategies of cell therapy in the treatment of gynecologic cancers |
| 10:30-10:50 | Coffee Break |
| Session IV: Access to Capital (Venture Capitalists¡¯ Perspectives) Chair: Chris Tan | |
| 10:50-11:10 | Howard S. Lee, Easy Life Science Management, Chinese Taipei Title: VC and financial management in bioindustry in Taiwan |
| 11:10-11:30 | Mik Park, STIC Investments, Korea Title: Biotechnology trend in the Asia Pacific Region |
| 11:30-11:50 | Kamarul Nizam Kassim, Malaysian Technology Development Corporation Sdn. Bhd, Malaysia Title: Malaysian Technology Development Corporation |
| 11:50-12:10 | Na-yeon Kim, Woori Investment Securities, Korea Title: Selection and concentration, the competitiveness of the Korean bio/healthcare sector |
| Session V: Panel Discussion Chair: Chris Tan | |
| 12:10-12:50 | Howard S. Lee, Mik Park, Kamarul Nizam Kassim, Na-yeon Kim |
| 12:50-13:00 | Concluding Remarks |
| 13:00-14:00 LUNCH | |
| 14:00-18:30 Social tour | |
| 14:00-17:30 A-IMBN Governing Council Meeting GC Members and A-IMBN Secretariat Only |
|